Background: Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) share metabolic alterations such as abnormal insulin and lipid metabolism and have some common genetic factors such as APOE genotype. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.